Galapagos (GLPG) announced the departure of its CFO and COO, Thad Huston, effective as of August 1. Huston has decided to leave the company and return to the U.S. for personal and professional reasons. Huston joined Galapagos NV in 2023 from Kite Pharma to support Galapagos’ transformation into a cell therapy company. The company expects to announce Huston’s successor in the coming months.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GLPG:
- Biotech stocks slide as Marks resignation seen being negative for sector
- Marks resignation ‘not good’ for biotech sector, says RBC
- Galapagos NV Releases 2024 Annual Report and Announces Shareholders’ Meeting
- Galapagos price target lowered to EUR 22 from EUR 28 at Deutsche Bank
- Galapagos’ Strategic Restructuring and Focus Shift: Analyst Holds Cautious Outlook